Business Wire Feed
CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer
– A Second Approval in First-Line Would Establish Trodelvy as a Backbone Therapy Across PD-L1 Status in the European Union – – ASCENT-04/KEYNOTE-D19 Demonstrated a Highly Statistically Significant and Clinically Meaningful Reduction in the Risk more...
VA Awards Salesforce $1.6B Contract to Transform Veteran Care and Services
SAN FRANCISCO & WASHINGTON--(BUSINESS WIRE)--Salesforce, the world’s #1 Agentic CRM, today announced that the U.S. Department of Veterans Affairs (VA) has awarded the company, through its distribution network, a $1.6 billion, three-year, Agentic Enterprise License more...
NADclinic and GCLS Announce Strategic Collaboration in Longevity and Performance Medicine Education
International collaboration to expand clinician education, professional standards and responsible adoption across longevity and performance medicineLONDON & GENEVA--(BUSINESS WIRE)--NADclinic Group and the Geneva College of Longevity Science (GCLS) have announced a strategic educational collaboration designed more...
Almirall H1 2026 Results
Almirall delivers solid H1 2026 results growing Net Sales by 7.5% and EBITDA by 23.7%, driven by its strong European Dermatology business – reiterating guidance aligned with long-term growth trajectory Net Sales increased by 7.5% more...
New GLP-1 Clinical Study Finds Calocurb® Reduces Body Weight and Body Fat Without Loss of Muscle Mass
The natural GLP-1 activator is clinically shown to support fat loss, including visceral fat reduction, while preserving lean muscleAUCKLAND, New Zealand--(BUSINESS WIRE)--Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, more...
Jamieson Wellness Inc. Announces Date of Second Quarter 2026 Financial Results and Conference Call
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its second quarter 2026 financial results after the market close on Thursday, August 6, 2026. The Company will more...
Align Technology Announces New Innovations to Advance Invisalign® Treatment Planning and Enhance Patient Engagement Through Its Integrated Align™ Digital Platform
Align™ Oral Health Suite updates – New multi-modal diagnostics integrations of Align™ X-ray Insights* and a gumline visualization tool to help doctors explain patients’ oral health conditions and treatment recommendations. New features in Invisalign® Outcome more...
Owlet to Report Second Quarter 2026 Financial Results on August 11, 2026
LEHI, Utah--(BUSINESS WIRE)--$owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) plans to announce second quarter 2026 financial results after market close on Tuesday, August 11, 2026. Owlet’s President, Chief Executive Officer, and Co-Founder, Kurt more...
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial more...
Xponential Fitness, Inc. to Announce Second Quarter 2026 Financial Results on Thursday, August 6th
IRVINE, Calif.--(BUSINESS WIRE)--Xponential Fitness, Inc. (NYSE: XPOF) (“Xponential” or the “Company”), one of the leading global franchisors of boutique health and wellness brands, today announced that it will release its second quarter 2026 financial results more...
Delcath Systems to Host Second Quarter 2026 Earnings Call
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on August 6, 2026, more...
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Genmab and AbbVie clarify overall survival (OS) was the sole U.S. primary endpoint in the Phase 3 EPCORE® DLBCL-1 trial and was not met COPENHAGEN, Denmark & NORTH CHICAGO, Ill.--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) and more...
AHF at AIDS 2026 Conference: AIDS Isn’t Over—and Syphilis Is Surging
RIO DE JANEIRO--(BUSINESS WIRE)--#AIDS--As a global leader in HIV and STI prevention and treatment, AIDS Healthcare Foundation (AHF) is once again bringing a bold and provocative message to the 26th International AIDS Conference (AIDS 2026) more...
Thyora Therapeutics Launches to Build a Next-Generation Platform for Covalent Drug Discovery
New biotechnology company emerges from breakthrough science published in Science with an integrated platform designed to advance a new generation of precision covalent medicinesTAMPA, Fla.--(BUSINESS WIRE)--#biotech--Thyora Therapeutics today emerged from stealth as a biotechnology company more...
UF Health Kidney and Liver Transplant Programs Once Again Rank Among Nation’s Best
Latest results from the Scientific Registry of Transplant Recipients place UF Health’s adult kidney transplant program first in the nation for one-year graft survival and its adult liver transplant program among the country’s top threeGAINESVILLE, more...
New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters
New research by Economist Enterprise, supported by Bayer, highlights the potential of self-care to become a more integrated component of modern health systems The research underscores that self-care works best when it is integrated into more...
Fisk Electric Adds $143 Million to Backlog for Electrical Contract at Children’s Health and UT Southwestern Medical Center New Dallas Pediatric Campus
LOS ANGELES--(BUSINESS WIRE)--#newaward--Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty construction company, announced today that its subsidiary, Fisk Electric Company (“Fisk”), has been awarded an electrical services contract for the more...
Feinstein Institutes Researchers Honored With Seven Prestigious Awards at the 2026 Shock Society Annual Conference
MANHASSET, N.Y.--(BUSINESS WIRE)--Responsible for millions of deaths worldwide, sepsis, a life-threatening condition where the body’s immune system spirals out of control, demands relentless and innovative research to advance understanding and deliver life-saving therapies. For their more...
Hallmark Names Shachar Rabbe as Chief Financial Officer
Veteran finance leader brings deep experience supporting high-growth organizations through transformation and changeDALLAS--(BUSINESS WIRE)--Hallmark Health Care Solutions (Hallmark), the leader behind Healthcare's Workforce Operating System, today announced that Shachar Rabbe has joined the organization as more...
Phillips Medisize to Present Strategies for Scaling Complex In Vitro Diagnostic (IVD) Builds Through Structured CDMO Collaboration at ADLM 2026
Lessons learned from scaling a diagnostic platform from early prototype to more than 10x production growth IVD innovators are facing manufacturing complexity and capital risks when trying to scale up commercial production. Phillips Medisize experts more...
U.S. Federal Court Permanently Bans 19 Online Sellers of Fake Urolithin A Supplements and Awards $5.3 Million in Damages to Timeline
Default judgment follows Timeline’s independent laboratory testing showing products sold under 19 online brands contained no detectable Urolithin A, or far less than advertisedLAUSANNE, Switzerland--(BUSINESS WIRE)--Timeline (Amazentis SA), the Swiss life-sciences company that pioneered the more...
Enveda’s Positive Phase 1B Results for ENV-294, a Potential First-in-Class Oral Therapy for Moderate-to-Severe Atopic Dermatitis, Were Presented at AAD Innovation Academy; Additional Details to Be Shared at EADV
BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a clinical-stage biotech company developing first-in-class small molecules derived from life’s chemistry, had results from its Phase 1b atopic dermatitis trial presented in New York at last week’s 2026 American Academy of more...
NovoMed PARTNERS Officially Launches to Build the Next Generation of Transformative Medical Technology Companies
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--#Advisory--NovoMed PARTNERS, a new healthcare innovation and growth platform founded by a team of trusted medtech entrepreneurs and executive operators, today officially launched its operations.Founded by Ramin Mousavi, former CEO of CathWorks, more...
Susan G. Komen® to Deliver Urgent Message at Second Annual October Party in Pink Event: “Ending Deaths from Breast Cancer is Within Our Grasp; Together We Will Make it Happen”
Annual “Un Gala” to Rally Survivors, Allies and Business Leaders to Drive Life-Saving Research and Critical Support for Breast Cancer Patients; Leading NYC-Based Corporations Pledge Their SupportNEW YORK--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast more...
Proximie Builds the Next Generation of Surgical Intelligence
Flagship multi-year partnership with UC San Diego Health combines Proximie’s largest deployment in the Americas with co-development of next-generation multimodal AI for perioperative intelligence. The collaboration will be working with NVIDIA Open Models and AI more...